Cas 1262536-74-2,(R)-N-(2-(4-(4-fluorophenyl)-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)ethyl)-3-phenylpropiolamide

1262536-74-2

Post Buying Request

Basic information

Product Name: (R)-N-(2-(4-(4-fluorophenyl)-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)ethyl)-3-phenylpropiolamide
Synonyms:
CAS NO:1262536-74-2
Molecular Formula:
Molecular Weight: 419.499
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (R)-N-(2-(4-(4-fluorophenyl)-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)ethyl)-3-phenylpropiolamide(CAS DataBase Reference)
NIST Chemistry Reference: (R)-N-(2-(4-(4-fluorophenyl)-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)ethyl)-3-phenylpropiolamide(1262536-74-2)
EPA Substance Registry System: (R)-N-(2-(4-(4-fluorophenyl)-1-oxo-2,8-diazaspiro[4.5]decan-8-yl)ethyl)-3-phenylpropiolamide(1262536-74-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1262536-74-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1262536-74-2 Suppliers

Recommended suppliers

1262536-74-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1262536-74-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,5,3 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1262536-74:
(9*1)+(8*2)+(7*6)+(6*2)+(5*5)+(4*3)+(3*6)+(2*7)+(1*4)=152
152 % 10 = 2
So 1262536-74-2 is a valid CAS Registry Number.

1262536-74-2Upstream product

7299-58-3 phenylpropiolyl chloride

1262536-74-2Downstream Products

1262536-74-2Relevant academic research and scientific papers

Isoform selective PLD inhibition by novel, chiral 2,8-diazaspiro[4.5]decan-1-one derivatives

Waterson, Alex G.,Scott, Sarah A.,Kett, Nathan R.,Blobaum, Anna L.,Alex Brown,Lindsley, Craig W.

, p. 3670 - 3673 (2018)

This letter describes the on-going SAR efforts to develop PLD1, PLD2 and dual PLD1/2 inhibitors with improved physiochemical and disposition properties as well as securing intellectual property position. Previous PLD inhibitors, based on a triazaspiro[4.5

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1262536-74-2